Curemark

Developer of therapeutics for the treatment of Autism and other neurological diseases

placeNew York City, New York, United States calendar_todayFounded 2004 groups9 employees language curemark.com

Registered entities

Innovation

25 patent families (21 granted) — focus: Human necessities, Physics & computing, Emerging technologies, Chemistry & metallurgy; filing pace slowing. Cited 56,126 times.

YearFilings
201512
201613
201710
201812
201914
20208
20217
20226
20232
20243
20253
20263

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Private equity133%
Accelerator & incubator133%
Coming soon